Eden Research (LON:EDEN) Shares Down 8.3% – What’s Next?

Eden Research plc (LON:EDEN)’s share price was down 8.3% during mid-day trading on Friday . The company traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.30 ($0.04). Approximately 280,171 shares were traded during trading, a decline of 70% from the average daily volume of 928,276 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Trading Down 3.3 %

The company has a market cap of £18.56 million, a P/E ratio of -12.19 and a beta of 0.92. The company has a current ratio of 3.80, a quick ratio of 2.42 and a debt-to-equity ratio of 1.26. The business has a 50 day moving average price of GBX 3.87 and a 200-day moving average price of GBX 3.95.

Insider Transactions at Eden Research

In related news, insider Lykele van der Broek acquired 256,000 shares of the company’s stock in a transaction dated Thursday, February 6th. The shares were bought at an average price of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($12,937.46). Also, insider Alexander John Abrey bought 540,540 shares of the firm’s stock in a transaction that occurred on Tuesday, January 28th. The shares were acquired at an average cost of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,317.25). Company insiders own 14.02% of the company’s stock.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.